Michael Ruggio is Taylor English’s D.C./Mid Atlantic Market Managing Partner. With more than 40 years of healthcare litigation, regulatory and compliance experience, he is able to represent hospitals, medical centers, durable medical groups, specialty physician practices, laboratories, pharmaceutical companies, and related medical entities across the board.
As a member of the Taylor English Litigation & Dispute Resolution Department, Mr. Ruggio’s unique in-depth experience allows him to provide strategic legal counsel not only in the representation on legal issues but the business implications of legal decisions. His cases have involved many areas of the Federal regulatory environment including the Department of Justice, Federal Trade Commission, Centers for Medicare and Medicaid, Food and Drug Administration, Drug Enforcement Administration and many others.
Having represented and litigated hundreds of cases involving complex healthcare issues including the False Claims Act, Stark, Anti-Kickback, HIPAA, Anti-Trust, reimbursement, product recalls and FDA regulatory matters, Mr. Ruggio can quickly assess the relevant regulatory issues. With this insight he can develop the best course of action for his clients.
As a former Department of Justice prosecutor and Assistant United States Attorney, Mr. Ruggio brings vast insight on the most effective white-collar criminal and civil strategy for clients facing major investigations and prosecutions in this regard.
Mr. Ruggio is also representing clients on cutting-edge developments in telehealth, AI, and blockchain Healthcare technology. These areas are creating a transformation and disruption in the entire healthcare service community. In this regard, he serves as an Adjunct Professor of Law at the University of Pittsburgh Law School teaching the first Blockchain Healthcare course at a law school.
Affiliations
- Catholic Charities
- Washington Area Lawyers for the Arts
- Federal Practice Bar
Recognitions
- Department of Justice Attorney General’s Award, 1995
- Super Lawyers, 2006 – 2007, 2010, 2012, 2018 – 2019
Practice Areas
- Antitrust
- Food and Drug Administration
- Health Care
- Litigation & Dispute Resolution
- Pharmaceutical
- Utilities & Regulated Industries
- White Collar Defense
Education
- University of Pittsburgh School of Law, JD, 1982
- New York University, BS, magna cum laude, 1978
Bar Admissions
- Virginia
- District of Columbia
- Pennsylvania
Courts
- Supreme Court of the United States
- U.S. Court of Appeals for the 3rd Circuit
- U.S. Court of Appeals for the 4th Circuit
insights
Chevron Overruled: A New Era of Regulatory Complexity for Healthcare and Pharma
July 25th, 2024
The June 2024 Supreme Court decision overturning the Chevron deference doctrine marks a substantial shift in the regulatory landscape for…
Read Moreinsights
Telehealth and the EHR: Allies in Fraud Prevention
July 18th, 2024
The expansion of telehealth, while offering undeniable benefits for access to care, necessitates a heightened focus on fraud prevention….
Read Moreinsights
Telehealth’s Untapped Frontier: Addressing Fraud Risks in Geographically Dispersed Care
July 16th, 2024
Telehealth’s ability to connect patients and providers across vast distances brings undeniable benefits. However, this very advantage…
Read Moreinsights
Focus on Medicare Advantage (MA) Programs: Addressing DOJ Scrutiny
July 11th, 2024
The Department of Justice (DOJ) continues to make investigating and prosecuting fraud within Medicare Advantage (MA) programs a priority….
Read More